CIK 0001000694 · Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222816046
- Phone
- 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-31 | YOUNG JAMES F Director | Sale | −5,400 | $8.00 | $43K | 51,760 |
| 2024-12-24 | YOUNG JAMES F Director | Sale | −4,600 | $8.48 | $39K | 57,160 |
| 2024-12-13 | King Rachel K. Director | Sale | −4,150 | $9.02 | $37K | 14,770 |
| 2024-06-21 | YOUNG JAMES F Director | Sale | −7,500 | $14.09 | $106K | 61,760 |
| 2024-06-18 | YOUNG JAMES F Director | Sale | −6,393 | $13.62 | $87K | 70,367 |
| 2024-06-18 | YOUNG JAMES F Director | Sale | −1,107 | $14.28 | $16K | 69,260 |
| 2024-06-17 | Dubovsky Filip President, R&D | Sale | −12,500 | $14.46 | $181K | 68,017 |
| 2024-06-17 | Dubovsky Filip President, R&D | Sale | −1,404 | $14.54 | $20K | 66,613 |
| 2024-05-14 | Dubovsky Filip President, R&D | Sale | −47,312 | $13.90 | $658K | 38,953 |
Page 1 of 1 · 9 trades